Myelosuppression after methotrexate, mitoxantrone, and mitomycin C.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D016685:Mitomycin; D008937:Mitomycins / Q000009:adverse effects; D008942:Mitoxantrone / Q000009:adverse effects; D011897:Random Allocation
D008937:Mitomycins; D016685:Mitomycin; D008942:Mitoxantrone; D008727:Methotrexate